3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Multiple Endocrine Neoplasia Type 2a
1
Lethal Congenital Contracture Syndrome 2
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
23
fludarabine
14
Rituximab
14
Specimen Handling
9
Magnetic Resonance Spectroscopy
8
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
polatuzumab vedotin
5
obinutuzumab
5
Biopsy
5
zanubrutinib
4
glofitamab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
fludarabine phosphate
3
acalabrutinib
3
Leukapheresis
3
Immunotherapy, Adoptive
3
Bendamustine Hydrochloride
3
venetoclax
2
pomalidomide
2
loncastuximab tesirine
2
etoposide phosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Antibodies, Bispecific
×
90 days
×
Clear all
No trials found.